You are here
The Independent Hospital Pricing Authority’s (IHPA) primary function is to calculate and deliver an annual national efficient price (NEP). The NEP is a major determinant of the level of Australian Government funding for public hospital services and provides a price signal or benchmark for the efficient cost of providing public hospital services.
The purpose of the Shadow Pricing Guidelines is to provide guidance for the use of shadow pricing in the development and implementation of changes to classification systems. The Shadow Pricing Guidelines establishes guiding principles for commencing shadow pricing, reporting requirements during the shadow pricing period and criteria for progression to pricing.
The Back-casting Policy outlines the process the Independent Hospital Pricing Authority follows when back-casting the national efficient price or national efficient cost to enable calculation of the Commonwealth’s funding contribution, as set out in the Addendum to the National Health Reform Agreement 2020–25 (clause A41).
Each year, the Independent Hospital Pricing Authority (IHPA) publishes the General List of In-Scope Public Hospital Services (the General List) as part of the National Efficient Price Determination. The General List defines public hospital services eligible for Commonwealth funding, except where funding is otherwise agreed between the Commonwealth and a state or territory.
The Independent Hospital Pricing Authority Work Program and Corporate Plan 2021–22 has been prepared in accordance with the requirements of section 225 of the National Health Reform Act 2011 and section 35(1)(b) of the Public Governance, Performance and Accountability Act 2013 for the reporting periods 2021–22 to 2023–24.
This document provides the technical specifications for how the Independent Hospital Pricing Authority (IHPA) developed the activity based funding models for the service streams to be funded for the National Efficient Price and the National Efficient Cost Determinations 2021–22.
This Framework outlines the processes to investigate cross-border and cost-shifting disputes following a request by a health minister to ensure the timely, equitable and transparent management of these disputes.
A jurisdiction may request the Independent Hospital Pricing Authority (IHPA) to consider any legitimate and unavoidable costs in the delivery of public hospital services. The purpose of this Framework is to outline the process by which IHPA will assess submissions from jurisdictions on legitimate and unavoidable cost variations and determine whether adjustments to the national efficient price are warranted.
The Assessing Materiality of Changes Proposed to the National Pricing Model document outlines the process the Independent Hospital Pricing Authority follows when assessing the materiality of proposed refinements to the national pricing model, such as new adjustments for specific cohorts of patients or the application of modified pricing approaches.
The Independent Hospital Pricing Authority (IHPA) is responsible for relevant data collections to enable activity based funding. IHPA’s Data Access and Release Policy outlines the principles and processes adopted by IHPA in the discretionary access and release of data collected under the National Health Reform Act 2011. The Policy provides guidance as to how IHPA will determine whether to release data.
The Management of Confidential Jurisdictional Information Protocol outlines the limited and prescribed purpose for which the Independent Hospital Pricing Authority can collect and analyse confidential jurisdictional information and the processes and controls in place to prevent unauthorised access and disclosure to unauthorised parties.
This Policy outlines the processes by which the Independent Hospital Pricing Authority stabilises volatility in the year-on-year price weights and adjustments to ensure funding stability and predictability for local hospital networks and hospital managers.
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Cost Determination 2021–22 (Determination):
The Pricing Framework for Australian Public Hospital Services 2021–22 (the Pricing Framework) is the key strategic document underpinning the national efficient price (NEP) and national efficient cost (NEC) Determinations for the financial year 2021–22 (NEP21 and NEC21 respectively).
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price Determination 2021–22 (Determination):